Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Marco Pappagallo, MD
Relmada Therapeutics, Inc, Coral Gables, Florida
JCP
Original Research
Esmethadone in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants
June 17, 2024
Although this trial of esmethadone did not meet its primary outcome, some secondary and post hoc outcomes were promising.
Maurizio Fava
,
Stephen M. Stahl
,
Luca Pani
, et al
JCP
Original Research
Effect of Time From Onset of MDD on Response to Esmethadone
May 13, 2024
Esmethadone 25 and 50 mg were more effective in reducing depression scale scores in patients who had a shorter time since their first major depressive episode.
Clotilde Guidetti
,
Sara De Martin
,
Giulia Serra
, et al
PCC
Original Research
REL-1017 Effects on Cognition in MDD
February 14, 2023
REL-1017 improved subjective measures of cognitive impairment, in addition to improving total MADRS and SDQ scores.
Clotilde Guidetti
,
Giulia Serra
,
Luca Pani
, et al